Abstract:Sjogren’s syndrome (SSj) is a systemic disease with autoimmune pathogenesis, with prevalent involvement of the lacrimal and salivary exocrine glands, classified as primary or secondary on the basis of the association with other rheumatic diseases.The epidemiological data in the literature are variable due to the heterogeneity of the populations examined and the different classification criteria used.In a recent systematic review by Baodon Qin et al. In a recent systematic review by Baodon Qin et al. the average incidence rate was 7 cases every 100,000 people/year (range 5-9) with higher values in the Caucasian and Asian populations, with a women/men ratio of 9.3 (95% CI 3.35 to 13.18), while the prevalence rate was 61 cases per 100,000 inhabitants (range 10-90) with a female/male ratio of 10.7 (95% CI 7.35-15.62).The aim of the study was to estimate the prevalence rate of primary SSj in real-life, through analysis of administrative data.An epidemiological research was carried out as at 31 December 2020, through the analysis of all adult patients residing in Piedmont (northwest of Italy) with exemption code (EC) for SSj (code 030) and any association with other ECs for rheumatological pathologies or for pathologies considered according to the 2016 EULAR/ACR classification criteria; specifically, the EC were considered for rheumatoid arthritis, ulcerative colitis and Crohn’s disease, chronic hepatitis (active), HIV infection, affected subjects from malignant neoplastic pathologies, tumors of uncertain behavior, systemic lupus erythematosus, Hashimoto’s thyroiditis, undifferentiated connective tissue disease; mixed cryoglobulinemia, antiphospholipid antibody syndrome (primary form), primary and familial amyloidosis, hereditary/familial autoinflammatory syndromes, microscopic polyangiitis, polyarteritis nodosa, sarcoidosis, dermatomyositis, polymyositis, mixed connective tissue disease, progressive systemic sclerosis.There were 3889 patients with EC for SSj as at 31 December 2020, of which 2611 with active EC.The number of assisted people alive with the aforementioned exemption was 2601, while those with other exemptions in the list were 1020. Of these patients, 1581 had only the exemption from code 030 as at 31 December 2020; the distribution of the other pathologies analyzed is shown in the tables below (Table 1).Of the total number of patients with active exemption, 2442 were female, while 159 were male, with a female/male ratio of 15.3; the distribution by gender is shown in Figure 1.Considering that the Piedmont population on 31 December 2020 was 4 274 945 inhabitants (ref: National Institute of Statistics), the estimated prevalence rate was 4.7 cases per 10 000 inhabitants.Table 1.Distribution of EC in patients residing in Piedmont as at 31/12/2020Diseases with ECN of patientsRheumatoid Arthritis250Ulcerative colitis and Crohn’s disease18chronic hepatitis52HIV infection2Systemic Lupus Erythematosus122Subjects affected by malignant neoplastic pathologies330Hashimoto’s thyroiditis280Undifferentiated Connective Tissue Sisease86Mixed Cryoglobulinemia6Antiphospholipid Antibody Syndrome8Primary And Familial Amyloidosis3Hereditary/Familial Autoinflammatory Syndromes1Microscopic Polyangiitis2Polyarteritis Nodosa1Sarcoidosis5Dermatomyositis2Polymyositis5Mixed connective tissue disease25Progressive systemic sclerosis56Figure 1.Distribution by gender of patients residing in Piedmont with exemption for Sjogren’s Syndrome. F: Female; M: MaleThis research has some limitations, including the retrospective design and the use of administrative data which may be affected by the aforementioned difficulty of classification as well as incorrect attributions of exemption, both for SSj and for associated pathologies.Our research highlights a number of patients with primary SSj lower than the prevalence figure that defines a rare disease, i.e. a prevalence of less than 5 cases per 10,000 inhabitants.Further studies are needed to confirm these preliminary data.[1]Baodong Qin et al. Ann Rheum Dis. 2015 Nov;74(11):1983-9.NIL.None Declared.

Ocular complications of primary Sjögren syndrome in men

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients with Primary Sjogren's Syndrome

Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients

The Proportion of Ocular Involvement and Characteristics of Dry Eye Parameters in Primary Sjögren's Syndrome Referred from the Rheumatology Department

Primary Sjögren's syndrome without ocular manifestation: a case report

Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjögren's syndrome

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients

Primary Sjögren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients.

Ophthalmologic profile of patients with systemic sclerosis

Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review.

Primary Sjögren's syndrome-related Choroiditis in a Newly Diagnosed Older Adult

Gynecological symptoms in primary and secondary Sjögren's syndrome and the effect of the disease on sexuality

Olfactory Impairment in Patients with Primary Sjogren’s Syndrome and Its Correlation with Organ Involvement and Immunological Abnormalities

POS0998-HPR THE EPIDEMIOLOGY OF PRIMARY SJOGREN’S SYNDROME: IS IT A RARE DISEASE?

Environmental factors in the pathogenesis of primary Sjögren's syndrome

Infectious Keratitis in Patients with Ocular Sjögren’s Syndrome

Infectious Keratitis in Patients with Ocular Sjögren's Syndrome

Increased Risk of Glaucoma in Patients with Sjögren's Syndrome: A Nationwide Population-Based Cohort Study

The clinical characteristics of 573 cases of primary Sj(o)gren's syndrome

Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy

Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome